
On Feb. 21, after some seven months in space, Varda Space Industries' W-1 capsule successfully returned to Earth, carrying with it a unique payload: the HIV/AIDS medication ritonavir.
Varda Space seeks to autonomously manufacture pharmaceuticals in microgravity, a strategy that could ultimately reduce the cost of life-saving drugs — and, according to a new preprint paper, the company is one step closer to achieving that goal.